James River Group Holdings (JRVR) reported an adjusted net operating loss of $0.10 per share for the third quarter, compared with a $0.32 profit a year earlier and $0.20 in the second quarter. Earnings fell 131.3% year over year, and revenue fell 14.5% to $147.71 million. No consensus estimate was available for comparison. The GAAP figure was far worse: a net loss of $4.08 per share, driven by a full $181.8 million goodwill impairment. Management stressed that the impairment is non-cash and dates to the 2007 buyout of the company, so it reflects no acquisition the company made. Even so, the write-off should not be dismissed. The release says the test was triggered by the sustained decline in the stock price and by E&S market conditions affecting the unit's actual and projected results. On the call, the company disclosed that the second-quarter test had passed by only about 3%. The impairment is accounting recognition of a deteriorating outlook, and that deterioration is the central story.
The operating loss came mainly from $19.2 million of adverse E&S reserve development identified in the annual ground-up valuation review. The charge was concentrated in a 2019-2023 product liability portfolio, tied to Florida construction defect claims, that is now fully in runoff. Management argued the problem is contained. It pointed to lower frequency and incurred losses in accident years since 2023, and the consolidated accident-year loss ratio held flat at 65.7%. The context is less comforting. The top-up adverse development cover was exhausted in the second quarter, so further development on older years now hits earnings directly. In addition, the E&S accident-year loss ratio edged up to 65.1% from 63.5%. The E&S combined ratio jumped to 108.5% from 88.3% a year ago. Excluding reserve development it was 93.4%, still well above the 86% posted in the fourth quarter of 2025.
The top line is shrinking faster than the cost base. Gross written premium fell 22%, with E&S down 19%. The decline came from roughly $15-17 million of habitational business non-renewed on competitive terms, about $30 million of exited construction and contract binding premium, and a 12% drop in average premium per bound policy. Net earned premium fell 14%. G&A declined 9%, but the expense ratio still climbed to 33.7% from 28.3%. Pricing is the more troubling trend. Casualty rate change has slid from 9% in 2025 to 7.7% in the first quarter, about 3% in the second, and roughly flat in the third. Management cited intensifying competition from MGAs and other E&S carriers, including on terms and conditions. That is a difficult backdrop for a company still rebuilding underwriting credibility.
There are genuine offsets. Submissions from active divisions rose 8%, double the 4% pace of the first half and the fastest since 2024. The AI-enabled underwriting workbench is now live in three departments with three more in process, and management cited early gains in quotes and binders per underwriter. Net investment income rose 9% sequentially to $22.2 million, helped by new-money yields above 5% and strong private credit returns. Still, submission growth matters only if it converts into adequately priced premium. Flat rates and falling premium per policy suggest that conversion is getting harder, not easier.
Balance-sheet erosion compounds the concern. Tangible common equity per share fell to $7.95 from $9.01 at the end of June and $8.94 at year-end. Year-to-date losses in accumulated other comprehensive income totaled $52 million, alongside the reserve charge. The low-to-mid-teen ROTCE outlook offered after the fourth quarter of 2025 was not reiterated. Management called it a difficult quarter that did not acceptably stack up, a sharp shift from the earlier "significant promise" framing. Two board departures add another governance question.
The market had already been leaning negative. Shares at $3.77 are down 10.2% since the open following the August report and sit 23.5% below the 200-day moving average of $4.93. That leaves the stock at less than half of tangible common equity per share. Earnings Whispers investor sentiment stayed negative and slipped modestly, from -0.31 to -0.36. Investors expected trouble, but this report gave them more reason to worry rather than less.
The bottom line is that the goodwill charge grabs the headline, but the more consequential developments are underneath it. Reserve development on legacy years now has no reinsurance cushion, casualty pricing has gone flat, premium is contracting, and management no longer reiterates its profitability target. Faster submission growth, AI productivity gains and rising investment income keep a recovery case alive. That case now depends on proving the post-2023 accident years are as clean as management claims, and until reserves stabilize, the discount to tangible book is likely to persist.